Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Cytokinetics (CYTK) Preferred Shares Issued: 2009-2013

Historic Preferred Shares Issued for Cytokinetics (CYTK) over the last 3 years, with Sep 2013 value amounting to $154.8 million.

  • Cytokinetics' Preferred Shares Issued changed negligibly% to $154.8 million in Q3 2013 from the same period last year, while for Sep 2013 it was $619.3 million, marking a year-over-year increase of 4.14%. This contributed to the annual value of $12.3 million for FY2012, which is 32.04% up from last year.
  • According to the latest figures from Q3 2013, Cytokinetics' Preferred Shares Issued is $154.8 million, which was down 0.00% from $154.8 million recorded in Q2 2013.
  • In the past 5 years, Cytokinetics' Preferred Shares Issued ranged from a high of $213.3 million in Q1 2011 and a low of -$217.3 million during Q4 2009.
  • For the 3-year period, Cytokinetics' Preferred Shares Issued averaged around $129.4 million, with its median value being $154.8 million (2013).
  • Examining YoY changes over the last 5 years, Cytokinetics' Preferred Shares Issued showed a top increase of 216.26% in 2012 and a maximum decrease of 33.18% in 2012.
  • Over the past 5 years, Cytokinetics' Preferred Shares Issued (Quarterly) stood at -$217.3 million in 2009, then increased by 3.28% to -$210.2 million in 2010, then rose by 2.60% to $142.5 million in 2011, then climbed by 8.64% to $154.8 million in 2012, then remained steady at $154.8 million in 2013.
  • Its Preferred Shares Issued was $154.8 million in Q3 2013, compared to $154.8 million in Q2 2013 and $154.8 million in Q1 2013.